Nifty
Sensex
:
:
10607.35
36033.06
-195.35 (-1.81%)
-660.63 (-1.80%)

Healthcare Services - Diagnostic

Rating :
80/99  (View)

BSE: 542650 | NSE: METROPOLIS

1556.20
-25.95 (-1.64%)
14-Jul-2020 | 3:48PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1579.80
  •  1612.65
  •  1525.75
  •  1582.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  116143
  •  1807.42
  •  2109.00
  •  995.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,037.86
  • 63.13
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,975.40
  • 0.84%
  • 14.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 56.90%
  • 3.13%
  • 3.25%
  • FII
  • DII
  • Others
  • 16.14%
  • 6.01%
  • 14.57%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.65
  • 10.85
  • 11.80

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.40
  • 11.66
  • 5.85

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.74
  • 14.82
  • 4.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
207
202
3%
223
190
17%
223
193
16%
203
176
16%
Expenses
156
145
7%
159
141
13%
170
150
13%
148
131
13%
EBITDA
51
57
-10%
64
49
29%
53
43
24%
55
44
24%
EBIDTM
25%
28%
29%
26%
24%
22%
27%
25%
Other Income
3
1
339%
2
2
-1%
2
5
-61%
2
2
-24%
Interest
2
0
3157%
2
0
1163%
0
0
0
2
0
935%
Depreciation
11
5
104%
11
5
99%
2
0
1810%
8
4
84%
PBT
23
52
-55%
53
46
15%
53
48
11%
40
42
-5%
Tax
8
17
-54%
11
14
-24%
10
18
-43%
12
14
-12%
PAT
15
35
-56%
42
32
32%
43
30
42%
27
28
-1%
PATM
7%
17%
19%
17%
19%
16%
13%
16%
EPS
3.06
6.96
-56%
8.30
6.28
32%
8.56
6.01
42%
5.38
5.46
-1%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
856
761
647
545
524
455
Net Sales Growth
13%
18%
19%
4%
15%
 
Cost Of Goods Sold
204
174
146
135
143
129
Gross Profit
652
588
501
410
381
326
GP Margin
76%
77%
77%
75%
73%
72%
Total Expenditure
633
557
469
391
388
337
Power & Fuel Cost
-
11
10
9
9
8
% Of Sales
-
1%
2%
2%
2%
2%
Employee Cost
-
176
147
128
116
95
% Of Sales
-
23%
23%
23%
22%
21%
Manufacturing Exp.
-
19
19
11
9
13
% Of Sales
-
3%
3%
2%
2%
3%
General & Admin Exp.
-
166
132
102
101
85
% Of Sales
-
22%
20%
19%
19%
19%
Selling & Distn. Exp.
-
0
0
0
0
0
% Of Sales
-
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
11
14
7
10
7
% Of Sales
-
1%
2%
1%
2%
1%
EBITDA
223
204
178
153
136
118
EBITDA Margin
26%
27%
28%
28%
26%
26%
Other Income
9
8
8
26
22
6
Interest
6
4
4
2
2
2
Depreciation
32
20
19
17
21
21
PBT
169
188
164
160
136
101
Tax
41
63
52
53
46
33
Tax Rate
24%
33%
32%
33%
36%
33%
PAT
128
122
104
107
74
61
PAT before Minority Interest
128
125
112
107
82
68
Minority Interest
0
-3
-8
0
-8
-7
PAT Margin
15%
16%
16%
20%
14%
13%
PAT Growth
2%
17%
-3%
46%
21%
 
EPS
25.31
24.03
20.60
21.20
14.55
12.04

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
419
415
323
265
361
Share Capital
10
10
10
10
10
Total Reserves
406
404
314
255
351
Non-Current Liabilities
142
148
16
1
10
Secured Loans
0
0
0
0
4
Unsecured Loans
0
0
0
3
4
Long Term Provisions
140
146
3
3
3
Current Liabilities
241
233
152
105
75
Trade Payables
43
35
36
38
34
Other Current Liabilities
50
42
102
38
35
Short Term Borrowings
18
0
0
0
0
Short Term Provisions
131
155
13
28
6
Total Liabilities
803
810
512
391
468
Net Block
213
207
202
148
153
Gross Block
271
246
220
273
260
Accumulated Depreciation
58
39
17
125
107
Non Current Assets
381
367
227
166
167
Capital Work in Progress
6
0
1
1
0
Non Current Investment
2
2
8
2
3
Long Term Loans & Adv.
150
149
13
16
10
Other Non Current Assets
10
9
2
0
0
Current Assets
422
443
285
225
302
Current Investments
31
100
134
79
167
Inventories
26
21
14
18
18
Sundry Debtors
137
101
80
77
76
Cash & Bank
80
60
41
43
29
Other Current Assets
147
5
4
3
11
Short Term Loans & Adv.
135
156
12
6
9
Net Current Assets
180
210
133
120
227
Total Assets
803
810
512
391
468

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
90
104
102
PBT
187
164
160
Adjustment
22
21
-3
Changes in Working Capital
-51
-23
-4
Cash after chg. in Working capital
158
162
153
Interest Paid
0
0
0
Tax Paid
-67
-58
-51
Other Direct Exp. Paid
0
0
0
Extra & Other Items
0
0
0
Cash From Investing Activity
35
2
-86
Net Fixed Assets
-27
-33
Net Investments
-37
41
Others
100
-6
Cash from Financing Activity
-118
-87
-17
Net Cash Inflow / Outflow
7
19
-1
Opening Cash & Equivalents
43
26
27
Closing Cash & Equivalent
51
43
26

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
83
433
339
278
366
ROA
16%
17%
24%
19%
14%
ROE
30%
30%
36%
26%
19%
ROCE
45%
45%
54%
40%
27%
Fixed Asset Turnover
2.94
2.78
2.21
1.97
1.75
Receivable days
57
51
53
53
61
Inventory Days
11
10
11
13
15
Payable days
36
38
45
44
46
Cash Conversion Cycle
33
23
18
22
30
Total Debt/Equity
0.04
0.00
0.00
0.03
0.04
Interest Cover
47
47
84
80
48

News Update


  • Metropolis Healthcare conducts COVID-19 tests for 150 Mauritius citizens
    18th May 2020, 14:02 PM

    The company has conducted COVID-19 tests who were stranded in India for more than 45 days

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.